scispace - formally typeset
M

Michael Fehr

Researcher at Leibniz University of Hanover

Publications -  16
Citations -  246

Michael Fehr is an academic researcher from Leibniz University of Hanover. The author has contributed to research in topics: Repolarization & QT interval. The author has an hindex of 9, co-authored 16 publications receiving 216 citations.

Papers
More filters
Journal ArticleDOI

Antiarrhythmic effects of free polyunsaturated fatty acids in an experimental model of LQT2 and LQT3 due to suppression of early afterdepolarizations and reduction of spatial and temporal dispersion of repolarization

TL;DR: The present study showed for the first time that PUFAs are effective in preventing TdP in an experimental model of long QT2 and LQT3 syndrome due to a reversion of AP prolongation, a reduction of spatial and temporal dispersion of repolarization and a suppression of EAD.
Journal ArticleDOI

Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.

TL;DR: The antiarrhythmic effect could be explained by a significant increase in postrepolarization refractoriness as a result of a more marked increase in aERP as compared with aAPD.
Journal ArticleDOI

Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.

TL;DR: Combined treatment with several non-cardiovascular QT-prolonging agents resulted in a remarkable occurrence of proarrhythmia, indicating an additive and significant prolongation of cardiac repolarization combined with an increased spatial dispersion of repolarized represents the underlying electrophysiological mechanism.
Journal ArticleDOI

Dronedarone and digitalis: individually reduced post-repolarization refractoriness enhances life-threatening arrhythmias

TL;DR: Ouabain treatment resulted in an increased ventricular vulnerability in chronically dronedarone-pretreated control and failing hearts, and led to a significant abbreviation of ventricular repolarization.